HLA Class II Histoglobulins Involvement in Mesangial IgA Glomerulonephritis (Berger’s Disease)

  • A. Volpi
  • L. Salvaneschi
  • A. Sessa
  • M. Martinetti
  • P. Serbelloni
  • M. Cuccia Belvedere
Part of the Developments in Nephrology book series (DINE, volume 24)

Abstract

Berger’s disease is characterized by mesangial granular deposits of IgA, with or without other immunoglobulin or complement protein deposits, and no evidence of systemic diseases. This form of glomerulonephritis has an unclear pathogenesis, but it is considered to be the consequence of immunological injuries. The diagnosis is based on the immunofluorescent examination of renal biopsy, laboratory data, and clinical findings. HLA histoglobulin frequency data, available from several studies, show that B35 (1,2) and B12 (3,4) seem to have a significant association with this disease. Fauchet (5) reported a statistical decrease of the DR3 frequency among the Berger’s patients. However, there is evidence of heterogeneity in these data: multiple reports from Japanese (6,7,8) and French (9,10) investigators show also a positive association with HLA-DR4 antigen.

Keywords

Creatinine Glomerulonephritis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Berthoux, F.C., Gagne, A., Sabatier, J.C., Ducret, F., Le Petit, S.C., Marcellin, M., Mercier, B. and Brizard, C.P. New Engl. J. Med. 298: 1034–1035, 1978.PubMedGoogle Scholar
  2. 2.
    Noel, L.H., Descamps, B., Jungers, P., Bach, J.F., Busson, M., Suet, C., Hors, J. and Dausset, J. Clin. Immunol. Immunopathol. 10:19–23, 1978.PubMedCrossRefGoogle Scholar
  3. 3.
    Richman, A.V., Mahoney, J.J. and Fuller, T.J. Ann. Intern. Med. 90: 201, 1979.PubMedGoogle Scholar
  4. 4.
    Savi, M;, Neri, T.M., Silvestri, M.G., Allegri, L. and Migone, L. Clin. Nephrol. 12: 45–46, 1979.PubMedGoogle Scholar
  5. 5.
    Fauchet, R., Gueguen, M. and Genetet, B. New Engl. J. Med. 302: 1033–1034, 1980.PubMedGoogle Scholar
  6. 6.
    Hiki, Y., Kobayash i, Y., Tateno, S., Sada, M. and Kashiwagi, N. Nephron 32: 222–226, 1982.PubMedCrossRefGoogle Scholar
  7. 7.
    Kashiwabara, H., Shishido, H., Tomura, S., Tuchida, H. and Miyajima, T. Kidney Int. 22: 377–382, 1982.PubMedCrossRefGoogle Scholar
  8. 8.
    Kashiwabara, H., Shishido, H., Yokoyama, T. and Miyajima, T. Tissue Antigens 16: 411–412, 1980.CrossRefGoogle Scholar
  9. 9.
    Fauchet, R., Le Pogamp, P., Genetet, B., Chevet, D., Gueguen, M., Simon, P., Ramee, M.P. and Cartier, F. Tissue Antigens 16: 405–410, 1980.PubMedCrossRefGoogle Scholar
  10. 10.
    Le Pogamp, P., Chevet, D. and Simon, P. Néphrologie 2: 43, 1981.Google Scholar
  11. 11.
    Reeves, W.G., Gelsthore, K., Van Der Minne, P., Torensma, R. and Tattersall, R.B. Clin. Exp. Immunol. 57: 443–448, 1984.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • A. Volpi
    • 1
  • L. Salvaneschi
    • 1
    • 2
  • A. Sessa
    • 1
  • M. Martinetti
    • 1
    • 2
  • P. Serbelloni
    • 1
  • M. Cuccia Belvedere
    • 1
    • 3
  1. 1.Unità Operativa di Nefrologia e DialisiOspedale di VimercateItaly
  2. 2.Centro Trasfusionale A.V.I.S. di PaviaItaly
  3. 3.Dipartimento di Genetica e Microbiologia dell’Università di PaviaItaly

Personalised recommendations